Page last updated: 2024-10-27

flumazenil and Mucopolysaccharidosis IV

flumazenil has been researched along with Mucopolysaccharidosis IV in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Mucopolysaccharidosis IV: Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santamaria, R1
Chabás, A1
Coll, MJ1
Miranda, CS1
Vilageliu, L1
Grinberg, D1

Other Studies

1 other study available for flumazenil and Mucopolysaccharidosis IV

ArticleYear
Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies.
    Human mutation, 2006, Volume: 27, Issue:10

    Topics: Adolescent; Adult; Base Sequence; beta-Galactosidase; Cells, Cultured; Child; Child, Preschool; Codo

2006